Vanda Pharmaceuticals Inc.

AED23.76
AED
Last updated on --.
24h volume1.18M
24h highest24.1686 AED
24h lowest23.3976 AED
24h Price movement+4.02%

VNDA recent prices

24 Hours
+4.02%+AED0.91828
30 days
-5.85%-AED1.470
60 days
-3.16%-AED0.77135
90 days
-27.72%-AED9.073

Key data

Previous close22.8467 AED
Market cap1.37B AED
Volume1.18M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-14.6189 AED
Net income (FY)-879.88M AED
Revenue (FY)799.94M AED
Last report date7 May 2026

About Vanda Pharmaceuticals Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersWASHINGTON
Employees (FY)533.00
Revenue per employee (FY)1.50M AED
Net income per employee (FY)-1.65M AED
Listed onNasdaq
Official website

VNDA conversion tables

VNDAVNDA
AEDAED
0.5 VNDA11.88 AED
1 VNDA23.76 AED
5 VNDA118.82 AED
10 VNDA237.64 AED
AEDAED
VNDAVNDA
0.5 AED0.021039 VNDA
1 AED0.042079 VNDA
5 AED0.21039 VNDA
10 AED0.42079 VNDA

FAQ

VNDA is trading at AED23.76, +4.02% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VNDA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VNDA is currently trading at AED23.76, +4.02% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VNDA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VNDA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VNDA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VNDA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Vanda Pharmaceuticals Inc.'s market cap is currently 1.37B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.18M
24h highest24.1686 AED
24h lowest23.3976 AED
24h Price movement+4.02%
VNDAVNDA
AEDAED
Start trade with VNDA Perpetual